Insulin pump not essential to benefit from continuous glucose monitoring

Lower-cost approach can deliver good results in people with type 1 diabetes, authors say

Real-time continuous glucose monitoring is superior to self-monitoring of blood glucose, regardless of the insulin delivery method, a study of suboptimally controlled people with type 1 diabetes shows.

Continuous glucose monitoring

In a repeat analysis of three-year results from the trial known as COMISAIR-2, updated with an additional 29 patients, four different treatment strategies for type 1 diabetes were compared by Czech researchers.

The 94 adult participants were allocated to either continuous glucose monitoring (CGM)